Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
28 March 2024
|
m 16:00 | Waldenström macroglobulinemia 2 changes history +311 [Jwarner (2×)] | |||
m |
|
16:00 (cur | prev) +312 Jwarner talk contribs →BDR {{#subobject:2529c7|Regimen=1}} | |||
m |
|
15:36 (cur | prev) -1 Jwarner talk contribs |
27 March 2024
|
m 00:27 | Acute promyelocytic leukemia 2 changes history -40 [Warner-admin (2×)] | |||
m |
|
00:27 (cur | prev) -32 Warner-admin talk contribs Text replacement - "One course of up to 90 days" to "Up to 90-day course" | |||
m |
|
00:27 (cur | prev) -8 Warner-admin talk contribs Text replacement - "One course of up to 60 days" to "Up to 60-day course" |
26 March 2024
23 March 2024
|
m 12:25 | B-cell acute lymphoblastic leukemia 3 changes history -54 [Jwarner (3×)] | |||
m |
|
12:25 (cur | prev) +2,810 Jwarner talk contribs →Relapsed or refractory | |||
m |
|
12:25 (cur | prev) -2,834 Jwarner talk contribs →Cytarabine & Mitoxantrone (MC) {{#subobject:6237f0|Regimen=1}} | |||
m |
|
12:25 (cur | prev) -30 Jwarner talk contribs →Inotuzumab ozogamicin monotherapy {{#subobject:d90806|Regimen=1}} |